Consistent with the physiological role of Mib1 in modulating SMN, pharmacological inhibition of Mib1 was shown to partially rescue the disease phenotype in a mouse model of SMA (Abera et al., 2016). This evidence concerns the gene MIB1 and proximal spinal muscular atrophy.